Submitted:
15 May 2023
Posted:
15 May 2023
You are already at the latest version
Abstract
Keywords:
Introduction
Methods
Results and Discussion
Causes of Hesitancy
| Freq. | Percent of responses | Percent of cases | |
|---|---|---|---|
| I never refused a vaccine recommended by a healthcare worker | 198 | 32.57 | 58.41 |
| Did not think it was needed | 61 | 10.03 | 17.99 |
| Did not have enough information on the vaccine | 80 | 13.16 | 23.6 |
| Did not think the vaccine was effective | 58 | 9.54 | 17.11 |
| Did not think the vaccine was safe | 74 | 12.17 | 21.83 |
| I was concerned about side effects | 93 | 15.3 | 27.43 |
| I had a bad experience with a previous vaccination | 23 | 3.78 | 6.78 |
| Did not know where to get the vaccination | 6 | 0.99 | 1.77 |
| Other logistic problems | 15 | 2.47 | 4.42 |
Implications on Economic Recovery
Conclusions
Author Contributions
Funding
Acknowledgments
Ethics
References
- Allington D, McAndrew S, Moxham-Hall V, Duffy B. (2021). Coronavirus conspiracy suspicions, general vaccine attitudes, trust and coronavirus information source as predictors of vaccine hesitancy among UK residents during the COVID-19 pandemic. Psychological Medicine. 2021;:1–12. [CrossRef]
- Al-Mohaithef, M., & Padhi, B. K. (2020). Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey. Journal of multidisciplinary healthcare, 13, 1657–1663. [CrossRef]
- Amit A.M.L, Pepito V.C.F, Sumpaico-Tanchanco L, Dayrit M.M. (2022) COVID-19 vaccine brand hesitancy and other challenges to vaccination in the Philippines. PLOS Glob Public Health 2(1): e0000165. [CrossRef]
- Anakpo, G., Nqwayibana, Z., & Mishi, S. (2023). The Impact of Work-from-Home on Employee Performance and Productivity: A Systematic Review. Sustainability, 15(5), 4529. [CrossRef]
- Anakpo, G.; Hlungwane, F.; Mishi, S (2023). The Impact of COVID-19 And Related Policy Measures on The Livelihood Strategies in Rural South Africa. Afr. Agenda.
- Anakpo, G & Mishi S. (2022). Hesitancy of COVID-19 vaccines: Rapid systematic review of the measurement, predictors, and preventive strategies, Human Vaccines & Immunotherapeutics. [CrossRef]
- Anakpo, G., Nqwayibana, Z., & Mishi, S. (2023). The Impact of Work-from-Home on Employee Performance and Productivity: A Systematic Review. Sustainability, 15(5), 4529. [CrossRef]
- Annas, S., & Zamri-Saad, M. (2021). Intranasal vaccination strategy to control the COVID-19 pandemic from a veterinary medicine perspective. Animals, 11(7), 1876. [CrossRef]
- Barello, S., Nania, T., Dellafiore, F., Graffigna, G. and Caruso, R., 2020. ‘Vaccine hesitancy’among university students in Italy during the COVID-19 pandemic. European journal of epidemiology, 35(8), pp.781-783. [CrossRef]
- Benoit, S.L. and Mauldin, R.F. (2021). The “anti-vax” movement: a quantitative report on vaccine beliefs and knowledge across social media. BMC Public Health 21, 2106 (2021). [CrossRef]
- Biswas, M.R.; Alzubaidi, M.S.; Shah, U.; Abd-Alrazaq, A.A.; Shah, Z. (2021). A Scoping Review to Find Out Worldwide COVID-19 Vaccine Hesitancy and Its Underlying Determinants. Vaccines 2021, 9, 1243. [CrossRef]
- Bono, S.A.; Faria de Moura Villela, E.; Siau, C.S.; Chen, W.S.; Pengpid, S.; Hasan, M.T.; Sessou, P.; Ditekemena, J.D.; Amodan, B.O.; Hosseinipour, M.C.; (2021). Factors Affecting COVID-19 Vaccine Acceptance: An International Survey among Low- and Middle-Income Countries. Vaccines 2021, 9, 515. [CrossRef]
- Brewer, Noel T., Buttenheim, Alison M., Clinton, Chelsea V., et al.. “Incentives for COVID-19 vaccination.” The Lancet Regional Health—Americas, 8, (2022) Elsevier: . [CrossRef]
- Callaghan, T. Moghtaderi A, Lueck J, Hotez P, Strych U, Dor A et al.(2021). Correlates and disparities of intention to vaccinate against COVID-19. Social Science & Medicine. 2021; 272:113638. [CrossRef]
- Campo-Arias, A., & Pedrozo-Pupo, J. C. (2022). Attitude towards COVID-19 vaccines in Colombian university students: Frequency and associated variables. Acta Bio Medica: Atenei Parmensis, 92(6). doi:10.23750/abm.v92i6.11533.
- Chadwick, A., Kaiser, J., Vaccari, C., Freeman, D., Lambe, S., Loe, B. S., Vanderslott, S, Lewandowsky, S., Conroy, M., Ross, A.R.N, Pollard,A.J., Waite, F., Larkin,M., Rosebrock, L., Jenner, L., McShane, H., Alberto Giubilini,A., Petit, A. and Yu, L. M. (2021). Online Social Endorsement and Covid-19 Vaccine Hesitancy in the United Kingdom. Social Media + Society, 7(2), 205630512110088. [CrossRef]
- Chevallier C, Hacquin AS, Mercier H. (2021). COVID-19 vaccine hesitancy: shortening the last mile. Trends Cogn Sci. 25 (5):331–33. [CrossRef]
- Coorper, S., van Rooyen, H., & Wiysonge, C. S. (2021). COVID-19 vaccine hesitancy in South Africa: how can we maximize uptake of COVID-19 vaccines? Expert Review of Vaccines, 1–13. [CrossRef]
- Dickerson, J., Lockyer, B., Moss, R.H., Endacott, C., Kelly, B., Bridges, S., Crossley, K.L., Bryant, M., Sheldon, T.A., Wright, J. and Pickett, K.E., (2021). COVID-19 vaccine hesitancy in an ethnically diverse community: descriptive findings from the Born in Bradford study. Wellcome Open Research, 6, p.23.
- Dubé, E., & MacDonald, N. E. (2022). COVID-19 vaccine hesitancy. Nature Reviews Nephrology, 1-2.
- Earnshaw, V. A., Eaton, L. A., Kalichman, S. C., Brousseau, N. M., Hill, E. C., & Fox, A. B. (2020). COVID-19 conspiracy beliefs, health behaviors, and policy support. Translational behavioral medicine, 10(4), 850-856. [CrossRef]
- Fisher, K. A., Bloomstone, S. J., Walder, J., Crawford, S., Fouayzi, H., & Mazor, K. M. (2020). Attitudes Toward a Potential SARS-CoV-2 Vaccine: A Survey of U.S. Adults. Annals of internal medicine, 173(12), 964–973. [CrossRef]
- Gqoboka, H., Anakpo, G., & Mishi, S. (2022). Challenges Facing ICT Use during COVID-19 Pandemic: The Case of Small, Medium and Micro Enterprises in South Africa. American Journal of Industrial and Business Management, 12(9), 1395-1401. DOI:10.4236/ajibm.2022.129077.
- Guidry, J.P.D.; Laestadius, L.I.; Vraga, E.K.; Miller, C.A.; Perrin, P.B.; Burton, C.W.; Ryan, M.; Fuemmeler, B.F.; Carlyle, K.E. (2021). Willingness to Get the COVID-19 Vaccine with and without Emergency Use Authorization. Am. J. Infect. Control 2021, 49, 137–142. [CrossRef]
- Hayawi, K., Shahriar, S., Serhani, M.A., Alashwal, H. and Masud, M.M., (2021). Vaccine versus Variants (3Vs): are the COVID-19 vaccines effective against the variants? A systematic review. Vaccines, 9(11), p.1305. [CrossRef]
- Jafta, K., Anakpo, G., & Syden, M. (2022). Income and poverty implications of Covid-19 pandemic and coping strategies: the case of South Africa. Africagrowth Agenda, 19(3), 4-7.
- Jolley, D., & Douglas, K. M. (2017). Prevention is better than cure: Addressing anti-vaccine conspiracy theories. Journal of Applied Social Psychology, 47(8), 459-469. [CrossRef]
- Katoto, P.D.M.C.; Parker, S.;Coulson, N.; Pillay, N.; Coorper, S.;Jaca, A.; Mavundza, E.; Houston, G.;Groenewald, C.; Essack, Z.; et al. Predictors of COVID-19 Vaccine Hesitancy in South African Local Communities: The VaxScenes Study. Vaccines 2022, 10, 353. [CrossRef]
- Khubchandani, J., Sharma, S., Price, J. H., Wiblishauser, M. J., Sharma, M., & Webb, F. J. (2021). COVID-19 Vaccination Hesitancy in the United States: A Rapid National Assessment. Journal of Community Health, 46(2), 270–277. [CrossRef]
- Komanisi, E., Anakpo, G., & Syden, M. (2022). Vulnerability to COVID-19 impacts in South Africa: analysis of the socio-economic characteristics. Africagrowth Agenda, 19(2), 10-12.
- Largent EA, Miller FG. Problems With Paying People to Be Vaccinated Against COVID-19. JAMA. 2021;325(6):534–535. [CrossRef]
- Larson, H. J., Jarrett, C., Eckersberger, E., Smith, D. M. D., & Paterson, P. (2014). Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007–2012. Vaccine, 32(19), 2150–2159. [CrossRef]
- Lyons, B., Merola, V., & Reifler, J. (2019). Not Just Asking Questions: Effects of Implicit and Explicit Conspiracy Information About Vaccines and Genetic Modification. Health Communication, 34(14), 1741-1750. [CrossRef]
- MacDonald, N. E., & SAGE Working Group on Vaccine Hesitancy (2015). Vaccine hesitancy: Definition, scope and determinants. Vaccine, 33(34), 4161–4164. [CrossRef]
- Makarovs K, and Achterberg P. (2017). Contextualizing educational differences in “vaccination uptake”: A thirty nation survey. Social Science & Medicine. 2017; 188:1–10. [CrossRef]
- Marzo, R.R.; Sami, W.; Alam, M.Z.; Acharya, S.; Jermsittiparsert, K.; Songwathana, K.; Pham, N.T.; Respati, T.; Faller, E.M.; Baldonado, A.M.; (2022). Hesitancy in COVID-19 Vaccine Uptake and Its Associated Factors among the General Adult Population: A Cross-Sectional Study in Six Southeast Asian Countries. Trop. Med. Health 2022, 50, 4. [CrossRef]
- Mylan S, and Hardman C. COVID-19, cults, and the anti-vax movement. Lancet. 2021 Mar 27;397(10280):1181. [CrossRef]
- Ndugga N, Hill L, Artiga S, and Parker N. (2021). Latest Data on COVID-19 Vaccinations by Race/Ethnicity [Internet]. KFF. 2021. Available from: https://www.kff.org/coronavirus-covid-19/issuebrief/latest-data-on-covid-19-vaccinations-race-ethnicity/ [Accessed on 23 March 2022].
- Neumann-Böhme, S., Varghese, N.E., Sabat, I., Barros, P.P., Brouwer, W., van Exel, J., Schreyögg, J. and Stargardt, T., (2020). Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. The European Journal of Health Economics, 21(7), pp.977-982. [CrossRef]
- Orosz, G., Krekó, P., Paskuj, B., Tóth-Király, I., Böthe, B. and Roland-Lévy, C. (2016) ‘Changing conspiracy beliefs through rationality and ridiculing’, Frontiers in Psychology, 7(279): 1525. [CrossRef]
- Pandolfi F, Franza L, Todi L, Carusi V, Centrone M, Buonomo A, Chini R, Newton EE, Schiavino D, Nucera E. The Importance of Complying with Vaccination Protocols in Developed Countries: “Anti-Vax” Hysteria and the Spread of Severe Preventable Diseases. Curr Med Chem. 2018;25(42):6070-6081. [CrossRef]
- Paul, E., Steptoe, A., & Fancourt, D. (2021). Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. The Lancet Regional Health—Europe, 1, 100012. [CrossRef]
- Pivetti, M., Di Battista, S., Paleari, F. G., & Hakoköngäs, E. (2021). Conspiracy beliefs and attitudes toward COVID-19 vaccinations: A conceptual replication study in Finland. Journal of Pacific Rim Psychology. [CrossRef]
- Razai, M. S., Osama, T., McKechnie, D. G. J., & Majeed, A. (2021). Covid-19 vaccine hesitancy among ethnic minority groups. BMJ, n513. [CrossRef]
- Roberts, B., N. Bohler-Muller, and J. Struwig, South African Social Attitudes Survey (SASAS) (Round 17) Brief report. Summary findings: Attitudes towards vaccination. 2021 March 12 [cited 2021 Mar 17], South Africa: Developmental, Capable and Ethical State (DCES) research division, Human Sciences Research Council (HSRC).
- Robertson E, Reeve K, Niedzwiedz C, Moore J, Blake M, Green M et al. Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study. Brain, Behavior, and Immunity. 2021; 94:41–50. [CrossRef]
- Robinson, E., Jones, A., and Daly, M. (2020) International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples. [CrossRef]
- Runciman, C., Alexander, K., Bekker, M., Bohler-Muller,N., Roberts, B., & Mchunu N., (2021) SA survey sheds some light on what lies behind coronavirus vaccine hesitancy, in Daily Maverick [Internet]. 2021 January 27 [cited 2021 Mar 17].
- 08 February.
- Savulescu, J., Pugh, J. & Wilkinson, D. Balancing incentives and disincentives for vaccination in a pandemic. Nat Med 27, 1500–1503 (2021). [CrossRef]
- Thirumurthy H, Milkman KL, Volpp KG, Buttenheim AM, Pope DG (2022) Association between statewide financial incentive programs and COVID-19 vaccination rates. PLoS ONE 17(3): e0263425. [CrossRef]
- Wiysonge, C. S., Ndwandwe, D., Ryan, J., Jaca, A., Batouré, O., Anya, B. P. M., & Coorper, S. (2022). Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?. Human vaccines & immunotherapeutics, 18(1), 1-3. [CrossRef]
- World Bank (2015). World development report: mind, society and behavior. World Bank Group, Washington, DC.
- World Health Organization (WHO). (2020). Behavioural considerations for acceptance and uptake of COVID-19 vaccines: WHO Technical Advisory Group on Behavioural Insights and Sciences for Health, Meeting Report, 15 October 2020. 2020.
- Wong CA, Pilkington W, Doherty IA, et al. Guaranteed Financial Incentives for COVID-19 Vaccination: A Pilot Program in North Carolina. JAMA Intern Med. 2022;182(1):78–80. [CrossRef]
| 1 | Raosoft a software that primarily calculates or generates the sample size of a research or survey (Raosoft Inc, 2004) |






| Hesitancy_safety | Coef. | St.Err. | t-value | p-value | [95% Conf | Interval] | Sig |
|---|---|---|---|---|---|---|---|
| age | -.065 | .271 | -0.24 | .811 | -.596 | .467 | |
| gender | .49 | .289 | 1.69 | .09 | -.077 | 1.057 | * |
| Religion:Christian | .073 | .332 | 0.22 | .826 | -.578 | .725 | |
| Education | -.32 | .31 | -1.03 | .302 | -.929 | .288 | |
| Income | .015 | .29 | 0.05 | .959 | -.553 | .583 | |
| Infor | -.063 | .302 | -0.21 | .835 | -.655 | .529 | |
| Satisfied | 1.642 | .327 | 5.03 | 0 | 1.002 | 2.282 | *** |
| Government | -.357 | .309 | -1.15 | .248 | -.964 | .249 | |
| Social | -.056 | .274 | -0.20 | .839 | -.592 | .481 | |
| Choice | -.133 | .295 | -0.45 | .653 | -.71 | .445 | |
| Constant | -2.376 | .305 | -7.78 | 0 | -2.974 | -1.778 | *** |
| Mean dependent var | 0.178 | SD dependent var | 0.383 | ||||
| Pseudo r-squared | 0.102 | Number of obs | 460 | ||||
| Chi-square | 44.176 | Prob > chi2 | 0.000 | ||||
| Akaike crit. (AIC) | 409.070 | Bayesian crit. (BIC) | 454.514 | ||||
| *** p < .01, ** p < .05, * p < .1 | |||||||
| Hesitancy-alternative | Coef. | St.Err. | t-value | p-value | [95% Conf | Interval] | Sig |
|---|---|---|---|---|---|---|---|
| age | -.432 | .298 | -1.45 | .148 | -1.017 | .153 | |
| gender | .686 | .297 | 2.31 | .021 | .104 | 1.268 | ** |
| Religion: Christian | -.131 | .346 | -0.38 | .706 | -.809 | .548 | |
| Education | .126 | .318 | 0.40 | .691 | -.496 | .748 | |
| Income | -.37 | .304 | -1.22 | .223 | -.965 | .225 | |
| Infor | .869 | .299 | 2.90 | .004 | .282 | 1.455 | *** |
| Satisfied | 1.356 | .317 | 4.27 | 0 | .734 | 1.977 | *** |
| Government | 1.418 | .298 | 4.76 | 0 | .835 | 2.001 | *** |
| Social | -.117 | .295 | -0.39 | .693 | -.695 | .462 | |
| Choice | 1.581 | .29 | 5.46 | 0 | 1.013 | 2.149 | *** |
| Constant | -3.085 | .369 | -8.37 | 0 | -3.808 | -2.363 | *** |
| Mean dependent var | 0.261 | SD dependent var | 0.440 | ||||
| Pseudo r-squared | 0.366 | Number of obs | 460 | ||||
| Chi-square | 193.310 | Prob > chi2 | 0.000 | ||||
| Akaike crit. (AIC) | 356.737 | Bayesian crit. (BIC) | 402.181 | ||||
| *** p < .01, ** p < .05, * p < .1 | |||||||
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).